Search Results < Yale School of Medicine

15 results

News
Yale-led trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer
New data from the ADAURA trial show significant disease-free survival for patients diagnosed with non-small cell lung cancer.
1 Feb 2023
News
Study Finds Large Gap in Breast Cancer Treatment Recommendations for Patients Aged 70 vs 69
Age-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new analysis of more than 500,000 patient records.
1 Feb 2023
News
Older Patients Left Behind in Progress Against Lung Cancer, Yale Study Shows
Although widespread use of immune checkpoint inhibitors (ICIs) in patients with advanced lung cancer has led to meaningful improvements in survival in younger patients, older patients have not experienced similar survival benefits, new research from Yale Cancer Center shows. The study was published in JAMA Oncology.
26 Jan 2023
News
Yale Scientists Enable Massively Parallel DNA Insertions Into Human Cells
Yale Cancer Center scientists have developed a novel technology that for the first time enables massively parallel DNA substitutions (known as “knock-ins”) into human cells by taking advantage of messenger RNA (mRNA), a platform now well-known from its use as the COVID vaccine vehicle.
26 Jan 2023
News
With Discovery, Oxygen's Role in Growth of Tumors Reconsidered
Yale researchers have made a discovery that changes conventional thinking about the role that oxygen plays in the growth of tumors—an area of cancer research that has been intensely studied in recent years.
Source: Yale SEAS
16 Dec 2022
News
Oncology Therapy at the End of Life: Have We Missed the Mark?
In a study published today in JAMA Oncology, researchers at Yale Cancer Center in collaboration with researchers from Flatiron Health, Inc., revealed that despite recommendations, aggressive cancer care at the end-of-life persists and there has been a substantial transition from the use of chemotherapy to immunotherapy.
21 Oct 2022
News
A New Path for Treating Brain Cancer With a Yale-developed Compound
Yale researchers have developed a new class of molecules that target some of the deadliest brain cancers while sparing healthy tissue. The discovery combines innovative synthetic chemistry and cutting-edge mechanistic studies in molecular biology, and offers a potentially powerful new approach to treating drug-resistant glioma tumors.
28 Jul 2022
News
Defining the Landscape of Prostate Cancer Treatment
Through the expertise of Isaac Kim, MD, PhD, MBA, Professor and Chair of Urology, new robotic technology at Smilow Cancer Hospital reduces the number of incisions for prostatectomies from six to two. As a result, men with prostate cancer are benefiting from a reduction in complications, pain, and hospital stays.
28 Jun 2022
News
PROTAC Research Takes Aim at Drug Resistant Prostate Cancer
A new class of cancer drugs is being investigated to target drug resistant prostate, lung, and colorectal cancers. Findings from Yale scientists...
16 May 2022
News
A Faster, Broader Pipeline for Phase I Clinical Trials Investigating Immunotherapies, Targeted Therapies
Immunotherapies and other treatments being investigated at Yale's Phase I Clinical Trial Program give hope to those with advanced cancer.
16 May 2022
News
BRCA Experts Rally to Research DNA Repair for Better Breast, Ovarian and Other Cancer Treatments
A diverse team of BRCA gene experts work together to unlock the secrets of DNA repair and develop better breast, ovarian and other cancer treatments.
16 May 2022
News
Pancreatic Cancer: Team Science Propels New Ideas
Team science propels research in pancreatic cancer, one of the most dangerous gastrointestinal cancers. Collaboration is key for Yale scientists.
16 May 2022
News
Viruses and Cancer: How a 45-year Legacy of Collaboration Led to Discoveries about Epstein-Barr, SV40
A 45-year grant led to genomic sequencing of the SV40 virus and other key findings about viruses that cause cancer…
11 May 2022
News
Head and Neck Cancer Research Leaps Forward With Yale’s NIH SPORE Award
The $11.7 million grant will help Yale’s head and neck cancer researchers address critical barriers to the treatment of HNSCC.
20 Sep 2020
News
Lung Cancer: Research Leads to New Immunotherapy Drug Approval,Insights on EGFR Resistance
Lung cancer treatment makes strides with new immunotherapy drug approval and important insights on the EGFR mutation.
19 Mar 2020